SCHEMBL26972709

SCHEMBL26972709

CCOP(C)(=O)Cc1cccc(Br)n1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 1/20 0.40
PGK2 P07205 1/20 0.40
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
HTR7 P34969 1/20 0.36
GRM5 P41594 1/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MBOAT4 Q96T53 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KCNH2 Q12809 1/20 0.33
PARP1 P09874 1/20 0.32
ACKR3 P25106 1/20 0.32
GAA P10253 1/20 0.31
KDM1A O60341 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13640312 0.86 PGK1 (0.41) PGK1PGK2CHRNB2CHRNA4HTR7
SCHEMBL30669248 0.86 PGK1 (0.41) PGK1PGK2CHRNB2CHRNA4HTR7
SCHEMBL3510117 0.84 PGK1 (0.42) PGK1PGK2CHRNB2CHRNA4HTR7
SCHEMBL3674807 0.77 PGK1 (0.53) PGK1PGK2CHRNB2CHRNA4HTR7
SCHEMBL3510122 0.74 PGK1 (0.50) PGK1PGK2CHRNB2CHRNA4HTR7
SCHEMBL5010543 0.73 PGK1 (0.52) PGK1PGK2KDM4ELMNAHPGD
SCHEMBL4542167 0.73 PGK1 (0.74) PGK1PGK2HPGDPARP1
SCHEMBL31557392 0.72 MEN1 (0.39) CHRNB2CHRNA4HTR7GRM5KDM4E
SCHEMBL19271839 0.72 GBA1 (0.40) KDM4ELMNAMBOAT4GAA
SCHEMBL6044969 0.71 PGK1 (0.60) PGK1PGK2KDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858910-B2 Pyridinylmethylenepiperidine derivatives and uses thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2024-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11858910-B2 Pyridinylmethylenepiperidine derivatives and uses thereof HTR1F, HTR1A, HTR5A PGK1 674/4885PGK2 732/4885CHRNB2 363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.